Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensus.

Dolores IslaJ de CastroR García-CampeloM MajemD VicenteOscar Juan Vidal

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

A consensus document is proposed to optimize the treatment strategy for untreated patients with a NSCLC with EGFR sensitizing mutations.

Keyphrases

small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
clinical practice
combination therapy
replacement therapy